| |
|
BETAMET®
Skin Ointment
|
|
|
|
|
COMPOSITION
Each gram contains
1 mg betamethasone valerate in an ointment base.
|
 |
PROPERTIES
BETAMET is an
topical corticosteroid has anti-inflammatory, antipruritic, vasoconstrictive
and antiproliferative effect.
|
|
INDICATIONS
BETAMET ointment
produces a rapid response in those inflammatory dermatoses that
are normally responsive to topical corticosteroid therapy, and is
often effective in the less responsive conditions such as psoriasis
BETAMET ointment is indicated for the treatment of eczema in children
and adults including atopic and discoid eczema, prurigo eczema,
prurigo nodularis, psoriasis (excluding widespread plague psoriasis),
neurodermatoses including lichen planus, seborrhoeic dermatitis,
contact sensitivity reactions and discoid lupus erythematosis.
|
|
DOSAGE
AND ADMINISTRATION
A
small quantity of BETAMET should be applied to the affected area
two or three times daily until improvement occurs. It may then be
possible to maintain by applying once a day or even less often.
|
|
CONTRAINDICATIONS
Hypersensitivity
to preparation, Rosacea, acne, perioral dermatitis and primary continuous
viral infections (e.g. herpes simplex, chicken pox) BETAMET is not
indicated in the treatment of primarily infected skin lesions caused
by infection with fungi (e.g. tinea, candidiasis), or bacteria (e.g.
impetigo), perianal and genital pruritus, dermatoses in children
under 1 year of age including dermatitis and napkin eruptions.
|
|
PRECAUTIONS
Long
term continuous topical therapy should be avoided where possible.
Particularly in infant and children as adrenal suppression can occur
even without occlusion. The face more than other areas in the body,
may exhibit atrophic changes after prolonged treatment with potent
topical corticosteroids. If applied to the eyelids care is needed
to ensure that the preparation does not enter the eyes, as glucoma
might result. If used in childhood or on the face, cources should
be limited if possible to five days and occlusion should not be
used. Appropriate antimicrobial therapy should be used whenever
treating inflammatory lesions, which have become infected. Any spread
of infection requires withdrawal of topical corticosteroids therapy
and systemic administration of antimicrobial agents. Topical corticosteroids
should not be used extensively by pregnant women in large amounts,
or for prolonged periods of time. Caution should be exercised also
when administered to nursing mothers.
|
|
SIDE
EFFECTS
Prolonged and
intensive treatment with highly active corticosteroids preparations
may cause local atrophic changes in the skin such as striae, thinning,
and dilation of the superficial blood vessels; particularly when
skin folds are involved. As with the other topical corticosteroids,
prolonged use with large amounts or treatment of extensive areas
can result in sufficient systemic absorption to produce suppression
of HPA axis. This effect is likely to occur in infants and children,
and if occlusive dressings are used. Infrequently, some other adverse
reactions may occur with topical corticosteroids including burning
sensation, itching, irritation, dryness, folliculitis, acneform
eruptions, hypopigmentation and perioral dermatitis.
|
|
PRESENTATIONS
BETAMET ointment
is available in tube containing 10g.
|
| |
|
|
|
